DOXOFYLLINE IP

✅ DOXOFYLLINE (CAS 69975-86-6) – PRODUCT DESCRIPTION

Doxofylline (CAS 69975-86-6) is a bronchodilator primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, leading to widening of the bronchi and making it easier for patients to breathe. Doxofylline is more selective than other traditional bronchodilators, like theophylline, and has a better safety profile, with reduced side effects. It is highly effective in managing wheezing, shortness of breath, and coughing in patients suffering from respiratory conditions. Available in oral tablet and syrup formulations, this white crystalline powder is supplied in pharmaceutical grades (IP) for clinical and commercial use. We supply Doxofylline to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring a reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (treatment of asthma, COPD, and other respiratory diseases)

• Healthcare (for breathing difficulties, wheezing, and shortness of breath)

• Research (studies on bronchodilators, respiratory medications, and anti-asthmatic treatments)

• Manufacturing (production of oral tablets, syrups, and other respiratory formulations)

🧪 Available Grades:

• Pharmaceutical Grade (IP)

• Reagent Grade

• Laboratory Grade

⚙️ Functions:

• Bronchodilator used to treat asthma, COPD, and wheezing

• Reduces inflammation and opens airways, improving breathing

• Less toxic than theophylline with fewer side effects

• Reagent in respiratory research and bronchodilator efficacy studies

• Improves lung function in chronic respiratory diseases

🧩 Classified Under:

• Pharmaceuticals

• Bronchodilators

• Anti-asthmatic Agents

• Active Pharmaceutical Ingredients (APIs)

• Respiratory Medications